{"id":"https://openalex.org/W2902196806","doi":"https://doi.org/10.1093/ofid/ofy210.2095","title":"2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems","display_name":"2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2902196806","doi":"https://doi.org/10.1093/ofid/ofy210.2095","mag":"2902196806"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofy210.2095","doi":"https://doi.org/10.1093/ofid/ofy210.2095","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.2095","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofy210.2095","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056029872","display_name":"Reeba John","orcid":"https://orcid.org/0000-0002-4731-7588","observed_orcids":["https://orcid.org/0000-0002-4731-7588"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reeba John","raw_affiliation_strings":["Baylor University Medical Center, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor University Medical Center, Dallas, Texas","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015861481","display_name":"Peter Colley","orcid":"https://orcid.org/0000-0003-1415-8602","observed_orcids":["https://orcid.org/0000-0003-1415-8602"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Colley","raw_affiliation_strings":["Baylor University Medical Center, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor University Medical Center, Dallas, Texas","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030096371","display_name":"Hoa Lan Nguyen","orcid":"https://orcid.org/0000-0002-4998-8510","observed_orcids":["https://orcid.org/0000-0002-4998-8510","https://orcid.org/0000-0002-2918-1162"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hoa Nguyen","raw_affiliation_strings":["Baylor University Medical Center, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor University Medical Center, Dallas, Texas","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042462726","display_name":"Mezgebe Berhe","orcid":"https://orcid.org/0000-0002-7287-567X","observed_orcids":["https://orcid.org/0000-0002-7287-567X"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mezgebe Berhe","raw_affiliation_strings":["Baylor University Medical Center, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor University Medical Center, Dallas, Texas","institution_ids":["https://openalex.org/I2802366037"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2802366037"],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10704801,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"suppl_1","first_page":"S730","last_page":"S731"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extended-spectrum-beta-lactamase","display_name":"extended-spectrum beta-lactamase","score":0.906000018119812},{"id":"https://openalex.org/keywords/bacteremia","display_name":"bacteremia","score":0.7630000114440918},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.9559999704360962},{"id":"https://openalex.org/keywords/carbapenems","display_name":"carbapenems","score":0.9919999837875366},{"id":"https://openalex.org/keywords/empirical-antibiotic-therapy","display_name":"empirical antibiotic therapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/in-hospital-mortality","display_name":"in-hospital mortality","score":0.7139999866485596},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.9259999990463257},{"id":"https://openalex.org/keywords/recurrent-bacteremia","display_name":"recurrent bacteremia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/bloodstream-infection","display_name":"bloodstream infection","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8973308801651001},{"id":"https://openalex.org/C2777858937","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Piperacillin/tazobactam","level":5,"score":0.8772809505462646},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.7978293895721436},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.6920949220657349},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.6799811124801636},{"id":"https://openalex.org/C2776685102","wikidata":"https://www.wikidata.org/wiki/Q410897","display_name":"Carbapenem","level":3,"score":0.6672313213348389},{"id":"https://openalex.org/C2779181126","wikidata":"https://www.wikidata.org/wiki/Q5374236","display_name":"Empiric therapy","level":3,"score":0.5859102606773376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5708134174346924},{"id":"https://openalex.org/C2779473907","wikidata":"https://www.wikidata.org/wiki/Q886695","display_name":"Blood culture","level":3,"score":0.4928731918334961},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.47711876034736633},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.45988261699676514},{"id":"https://openalex.org/C191093355","wikidata":"https://www.wikidata.org/wiki/Q9250577","display_name":"Exact test","level":2,"score":0.44976574182510376},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.43692445755004883},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.3418771028518677},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3338679373264313},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.1655074656009674},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.15025615692138672},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.07544109225273132},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofy210.2095","doi":"https://doi.org/10.1093/ofid/ofy210.2095","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.2095","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5239602","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6255585","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6255585","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6255585","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofy210.2095","doi":"https://doi.org/10.1093/ofid/ofy210.2095","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.2095","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2935120437","https://openalex.org/W2131640216","https://openalex.org/W2565295786","https://openalex.org/W7099688527","https://openalex.org/W2466594665","https://openalex.org/W7115719476","https://openalex.org/W2342144563","https://openalex.org/W2755772489","https://openalex.org/W7062504091","https://openalex.org/W2163090028"],"abstract_inverted_index":{"Infections":[0],"due":[1,11,32],"to":[2,12,33,82,124,224],"extended":[3],"spectrum":[4],"\u03b2-lactamase":[5],"(ESBL)":[6],"producing":[7],"bacteria":[8,114],"are":[9],"problematic":[10],"the":[13,25,40,164,174,201,301,321],"association":[14],"with":[15,45,107,112,286,295],"worse":[16],"outcomes":[17,291],"and":[18,39,87,128,168,176,188,222,314],"limited":[19],"treatment":[20,56],"options.":[21],"Carbapenems":[22],"(CBPs)":[23],"remain":[24],"drugs":[26],"of":[27,35,74,185,206,215,242,252,303,316,324],"choice":[28],"for":[29,57,64,144,156,278],"these":[30,58,307],"infections":[31,59],"evidence":[34,63],"a":[36,108,135,154,276,298,330],"mortality":[37,233],"benefit":[38],"mixed":[41],"clinical":[42],"efficacy":[43],"associated":[44],"piperacillin/tazobactam":[46],"(PTZ)":[47],"despite":[48],"often":[49],"reported":[50,338],"in":[51,80,231,284,320],"vitro":[52],"activity.":[53],"While":[54],"definitive":[55,84,157],"has":[60],"been":[61],"well-defined,":[62],"appropriate":[65,83],"empiric":[66,89,191,311,317],"therapy":[67,85,319],"remains":[68],"inconclusive.":[69],"Rapid":[70],"molecular":[71,118,305],"assays":[72],"capable":[73],"identifying":[75],"ESBL":[76,218,225,262,287],"markers":[77],"may":[78],"aid":[79],"switching":[81],"sooner":[86],"spare":[88],"carbapenem":[90],"use.":[91],"This":[92,282],"multicenter":[93],"retrospective":[94],"study":[95,283],"at":[96,99],"9":[97],"sites":[98],"Baylor":[100],"Scott":[101],"&":[102],"White":[103],"Health":[104],"included":[105],"patients":[106,181,285],"positive":[109,216],"blood":[110],"culture":[111],"ESBL-producing":[113],"identified":[115],"by":[116],"rapid":[117,304],"assay":[119],"from":[120],"January":[121],"1,":[122],"2014":[123],"September":[125],"22,":[126],"2017":[127],"were":[129,138,161,171,198],"empirically":[130,294],"prescribed":[131],"either":[132],"PTZ":[133,143,192,274,296,312],"or":[134,150,193,260,275,297],"CBP.":[136,299],"Patients":[137],"excluded":[139],"if":[140],"they":[141],"continued":[142],"more":[145],"than":[146],"24H":[147,323],"after":[148],"identification":[149],"did":[151],"not":[152],"receive":[153],"CBP":[155,277,318],"therapy.":[158],"Categorical":[159],"data":[160,170],"analyzed":[162],"using":[163,173],"Fisher\u2019s":[165],"exact":[166],"test":[167],"continuous":[169],"evaluated":[172],"t-test":[175],"Wilcoxon":[177],"rank-sum":[178],"test.":[179],"117":[180],"met":[182],"inclusion":[183],"criteria":[184],"which":[186],"66":[187],"51":[189],"received":[190,273],"CBPs,":[194],"respectively.":[195,281],"Baseline":[196],"characteristics":[197],"similar":[199,290],"between":[200,270],"groups,":[202],"including":[203],"suspected":[204],"source":[205],"bacteremia,":[207],"prior":[208,211],"hospital":[209,232,240],"stay,":[210],"antibiotic":[212],"therapy,":[213],"history":[214],"non-blood":[217],"culture,":[219],"ICU":[220,250],"admission,":[221],"time":[223],"identification.":[226],"There":[227],"was":[228],"no":[229],"difference":[230],"(3":[234],"vs.":[235,245,255,265],"7.8%,":[236,266],"P":[237,247,257,267],"=":[238,248,258,268],"0.4),":[239],"length":[241,251],"stay":[243,253],"(6.1":[244],"5.9%,":[246],"0.88),":[249],"(4.7":[254],"3.3%,":[256],"0.39)":[259],"recurrent":[261],"bacteremia":[263,288],"(7.6":[264],"0.99)":[269],"those":[271],"that":[272,310],"initial":[279],"treatment,":[280],"showed":[289],"when":[292],"treated":[293],"In":[300],"era":[302],"assays,":[306],"results":[308],"suggest":[309],"use":[313],"avoidance":[315],"first":[322],"infection":[325],"can":[326],"be":[327],"considered":[328],"until":[329],"microbiological":[331],"diagnosis":[332],"is":[333],"confirmed.":[334],"All":[335],"authors:":[336],"No":[337],"disclosures.":[339]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-12-11T00:00:00"}